A special morning tea was held at the ACV/GARDS office on the 22nd November, where members and the general public were invited to come along and learn so much more about asbestos in the community. On hand to stimulate conversation were samples containing asbestos such as necklaces, earrings, crayons, children’s science kits, building materials such as brick cladding, asbestos fibre samples, sealant, brakes, pot stands, gaskets and so much more. In attendance were hygienists, asbestos litigation lawyers and local council employees for the general public to ask those questions they have always wanted to know and never got around to asking.
All who attended enjoyed the chat and banter along with the scones jam and cream – tea and coffee. It was a very enjoyable morning with much information sharing. All who attended said that the morning had been insightful and enjoyable. Thank you to all who came along and made the morning such a success. Below are some of those who attended.
ACV/GARDS crew attended the Asbestos Safety & Eradication Agency International Asbestos Conference in Adelaide from the 12th – 15th November. We caught up with many old friends and some new ones. It was great to spend time with Terry Miller and Kat Wake-Burge & the rest of the team from AVA. We also had a chance to chat with our old friend Matt Peacock seasoned ABC Journalist and spend some time with Tanya Segelov along with many others such as Linda Reinstein CEO Asbestos Disease Awareness Org United States. We also had the fortunate opportunity to meet a very lovely lady named Kathleen Ruff Founder & Head of RightOnCanda.ca. Dr Tom John Medical Oncologist & John Cannings from Rare Cancers Australia gave some very interesting news in the research and drug area – it was good to catch up with Dr Tom again. It was a pleasure to chat and catch up with Serafina Salucci a very strong advocate for asbestos sufferers – keep up the good work Serafina. Two of our members who live in Adelaide met with us for dinner while we were there – Jane West and Terry Wilkins.
We thoroughly enjoyed seeing everyone. It was a very exhaustive visit to Adelaide learning so much more about asbestos issues from all over Australia and Internationally – but a really rewarding one – We will be looking forward to the next catch up with everyone.
The fight to Ban Asbestos around the world is only just beginning to ramp up – the International slogan is:
“Asbestos – Not Here – Not Anywhere”
If you would like to know more about the ASEA Adelaide 2016 Conference access this link
Cancer Council Victoria has announced a much-needed injection of funds into mesothelioma research today, providing hope for the future in the fight against the devastating form of cancer.
160 people are diagnosed with mesothelioma each year in Victoria, and 726 nationally. It remains one of the deadliest cancers, with a 5-year survival rate of just 7%.
Cancer Council Victoria hopes this can be improved with more research.
Thanks to the philanthropy of the late Lyall Watts, his partner Gary Kenny and Lyall’s sister Sandra Harbison and mother Marjorie Watts, Cancer Council Victoria has been able to award $700,000 for two new research grants.
Dr Peter Janes at Monash University and Prof Andrew Scott and A/Prof Tom John at the Olivia Newton-John Cancer Research Institute have received funding to continue their work into targeted antibody therapies for malignant mesothelioma.
“We developed antibodies against two cancer targets abundant in malignant mesothelioma, which are currently in trials for other cancers,” Dr Janes said.
“We will screen mesothelioma patient tissues to define eligible patient populations and use mesothelioma mouse models to develop effective therapy strategies. Our team of translational cancer researchers and clinicians, with collaborative ties to trial sponsors, is uniquely positioned to develop strategies that allow rapid translation into clinical trials.”
At the Peter MacCallum Cancer Centre, Associate Professor Kieran Harvey and his team hope to decipher the role of the Hippo pathway in mesothelioma.
“The Hippo pathway is an important group of genes that relays messages from the surface of the cell to the nucleus to change the cell’s behaviour. Normally it controls how big our organs grow,” A/Prof Harvey said.
“The activity of Hippo pathway genes can change and cause cancer and this occurs in at least half of mesotheliomas. We will use cutting edge technologies to investigate the causes of mesothelioma and search for possible new treatments of this disease by using our unique knowledge of the Hippo pathway.”
“The Lyall Watts Mesothelioma Research grants are an important contribution to helping improve treatments and provide hope for those affected by this insidious disease,” CEO Todd Harper said.
Both projects will be funded for three years.
Friday 28th October 2016